Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-12-18
2010-10-26
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000
Reexamination Certificate
active
07820665
ABSTRACT:
The present invention relates to imidazopyridazine compounds of Formula I, such as representative structure A, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase;methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.
REFERENCES:
patent: 3725428 (1973-04-01), Janiak
patent: 2003/0153568 (2003-08-01), Cusack
patent: 2009/0098086 (2009-04-01), Zask et al.
patent: 2009/0181963 (2009-07-01), Dehnhardt et al.
patent: 2009/0192176 (2009-07-01), Zask et al.
patent: WO 2004/007491 (2004-01-01), None
patent: WO 2004/010995 (2004-02-01), None
patent: WO 2004/098494 (2004-11-01), None
patent: WO 2005/003127 (2005-01-01), None
patent: WO 2005/070920 (2005-08-01), None
patent: WO 2006/039718 (2006-04-01), None
patent: WO 2006/040318 (2006-04-01), None
patent: WO 2006/044732 (2006-04-01), None
patent: WO2006/046031 (2006-05-01), None
patent: WO 2006/051270 (2006-05-01), None
patent: WO 2006/052913 (2006-05-01), None
patent: WO 2007/016392 (2007-02-01), None
patent: WO 2007/076092 (2007-07-01), None
patent: WO 2007/095588 (2007-08-01), None
patent: WO 2007/095588 (2007-08-01), None
patent: WO 2007/129044 (2007-11-01), None
patent: WO 2007/129052 (2007-11-01), None
patent: WO2007/132171 (2007-11-01), None
patent: WO 2007/134828 (2007-11-01), None
patent: WO 2007/135398 (2007-11-01), None
patent: WO 2008/003856 (2008-01-01), None
patent: WO 2008/012326 (2008-01-01), None
patent: WO 2008/016131 (2008-02-01), None
patent: WO 2008/025821 (2008-03-01), None
patent: WO 2008/037477 (2008-04-01), None
patent: WO 2008/052733 (2008-05-01), None
patent: WO2008/070740 (2008-06-01), None
patent: WO2008/073785 (2008-06-01), None
patent: WO2008/101979 (2008-08-01), None
patent: WO2008/115974 (2008-09-01), None
patent: WO 2008/116129 (2008-09-01), None
patent: WO 2008/133192 (2008-11-01), None
patent: WO 2008/138834 (2008-11-01), None
patent: WO 2008/138889 (2008-11-01), None
patent: WO2008/141065 (2008-11-01), None
patent: WO 2008/144463 (2008-11-01), None
patent: WO 2008/144464 (2008-11-01), None
patent: WO 2008/144465 (2008-11-01), None
patent: WO 2008/150827 (2008-12-01), None
patent: WO2008/152387 (2008-12-01), None
patent: WO 2008/152387 (2008-12-01), None
patent: WO2008/152390 (2008-12-01), None
patent: WO2008/152394 (2008-12-01), None
patent: WO 2008/157191 (2008-12-01), None
patent: WO 2009/000832 (2008-12-01), None
patent: WO2009/008748 (2009-01-01), None
patent: WO 2009/010530 (2009-01-01), None
patent: WO 2009/017822 (2009-02-01), None
patent: WO2009/053715 (2009-04-01), None
patent: WO2009/053716 (2009-04-01), None
patent: WO2009/055418 (2009-04-01), None
patent: WO2009/068482 (2009-06-01), None
patent: WO2009/070524 (2009-06-01), None
patent: WO2009/081105 (2009-07-01), None
patent: WO2009/097446 (2009-08-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim, preface and relevant pages attached.
Kubinyi ed. 3D QSAR in Drug Design: Ligand-Protein Interactions and Molecular Similarity, vol. 2-3, Springer, 1998, 800 pages, relevant portion attached.
Altland H.W., et al., A Facile Synthesis of 2-Aminothiazolo[5,4-b]- and 2-Aminothiazolo [4,5-c] pyridines, Journal of Heterocyclic Chemistry, Jan. 1, 1977, pp. 129-134, vol. 14, Heterocorporation. Provo, US.
P. Garay et al., Synthese et etude des activites antiparasitaires et molliscicides de derives polycycliques de la pyridine, European Journal Medicinal Chemistry, 1978, pp. 171-175, vol. 13, No. 2.
P. Garay et al., Synthese et etude des activites antiparasitaires et molliscicides de derives polycycliques de la pyridine, European Journal Medicinal Chemistry, 1978, pp. 171-175, vol. 13, No. 2. (English—Translation).
Patil V.H., et al., Synthesis of some sulphanilamido-benzothiazolyl thiazole derivatives as antibacterial agents, Journal of the Indian Chemical Society, Dec. 1, 1979, pp. 1243-1245, vol. 56, No. 12, The Indian Chemical Society, Calcutta, IN.
Patil V.H., et al., Synthesis of 2-arylamino-4- not 2′-(P-Acetamido-Benzenesulphonamido)-6′-Benzothiazolyl 3/4 Thiazoles & 2-Arylamino-4-(2′-Sulphanilamido-6′ -Benzothiazolyl)Thiazoles, Indian Journal of Chemistry, Section B: Organic, Incl. Medicinal, Jan. 1, 1979, pp. 519-521, vol. 17B, No. 5, Publications & Informations Directorate, New Delhi, IN.
Cosulich et al., New Thiazole Pyridine Sulfonamides as Orally Bioavailable Highly Potent PI3 Kinase Inhibitors, Cancer and Infection Research Area. AstraZeneca, Alderley Park, Cheshire, UK. Keystone Conference Presentation, New Mexico, Feb. 15-20, 2007.
Camps et al., Blockade of PI3K gamma Suppresses Joint Inflammation and Damage in Mouse Models of Rheumatoid Arthritis, Nature Medicine, Sep. 2005, pp. 936-943, vol. 11, No. 9.
Hayakawa, et al., Synthesis and Biological Evaluation of Imidazo[1,2-alpha]pyridine derivatives as novel PI3 kinase p110alpha Inhibitors, Bioorganic and Medical Chemistry, 2007, pp. 403-412, vol. 15.
Knight, et al., A Pharmacological Map of the PI3-K Family Defines a Role for p110alpha in Insulin Signaling, Cell, May 19, 2006. pp. 733-747, vol. 125.
Knight, et al., Supplemental Data—A Pharmacological Map of the PI3-K Family Defines a Role for p110alpha in Insulin Signaling, Cell, May 19, 2006, pp. 733-747, vol. 125.
Partial International Search Report, International Application No. PCT/US2008/013940.
International Search Report, International Application No. PCT/US2008/009312.
Booker Shon
Kim Tae-Seong
Liao Hongyu
Liu Longbin
Norman Mark H.
Amgen Inc.
Crissey Todd M.
Fierro Alicia L
Shameem Golam M. M.
LandOfFree
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridazine inhibitors of PI3 kinase for cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridazine inhibitors of PI3 kinase for cancer treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157621